Fundraising Fox

Nimble Science

Founded 2018 · 8 known investors

nimblesci.com

Nimble Sciences develops the SIMBA GI Platform, a swallowable capsule system that autonomously collects, seals, and preserves fluid biopsies from the small intestine to generate multi-omic datasets of the GI tract. The platform is used to characterize the gut microbiome, correlate multi-omic profiles with disease states, and support therapeutic and microbiome-related research in gastrointestinal care.

BiotechDigital HealthMedical Devices

Investors · 8

Also in the syndicate · 1

Fusion Fundlead

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 4

by search overlap

Companies competing with Nimble Science for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Nimble Science do?
Nimble Sciences develops the SIMBA GI Platform, a swallowable capsule system that autonomously collects, seals, and preserves fluid biopsies from the small intestine to generate multi-omic datasets of the GI tract. The platform is used to characterize the gut microbiome, correlate multi-omic profiles with disease states, and support therapeutic and microbiome-related research in gastrointestinal care.
Who are Nimble Science's investors?
Nimble Science's investors include First Spark Ventures, Llc, Fusion, Startup TNT, Thin Air Labs, UCeed Funds, BoxOne Ventures, Seventure Partners.